Antithrombin III (AT III) is a blood protein that inhibits or stops the clotting factors in blood. Approximately 75% of the body's plasma coagulation inhibitory activity is derived from AT III. AT III deficiency is a rare inherited or spontaneously occurring condition that affects one in every 2,000 to 5,000 males and females worldwide. Individuals with the condition lack the AT III protein and spontaneous clotting can occur as a result of normal, daily activity. A doctor or healthcare provider prescribes Antithrombin III.
Please note: Country-specific regulatory requirements limit the information we can provide about our products. In addition, approved indications (uses), product labels, and packaging for a prescription drug may differ between countries. Please refer to the prescribing information provided for your country of residence.
Thrombate III®, Antithrombin III (Human) reaches patients around the world.
|
